title: [New forms of Parkinsonism in hospice care].
abstract: Parkinson's disease is a well known phenomenon with characteristic evolution and clinical picture although having considerable variation in its presenting symptoms. From an extra-hospital consulting room we carried out a study of the characteristics of the clinical presentation of parkinsonisms in a series of one hundred cases so diagnosed from onset. The average age of the patients was around 66 years with a slight female predominance. Most patients had been referred to us by their own GPs. Some 70% of patients came suffering from shaking, 23% for slowness or clumsiness and 10% for unsteadiness. 71% of cases had unilateral onset and 29% had bilateral onset. Most of the patients we saw arrived at level 2 on the Hoehn and Yahr scale. The duration of the symptoms was approximately one year. In some 27% of cases drug consumption might have brought on parkinsonism. Almost two-thirds of these cases brought about by medicaments were being treated with cinaricine or flunaricine and nearly one third were undergoing neuroleptic treatment. Practically one out of every four cases, and one out of three women, could be considered as having iatrogenic parkinsonism. The onset of shaking with bilateral affectation is particularly suggestive of drug induced parkinsonism.
authors.affiliation: Servicio de Neurologia, Hospital Universitari La Fe, Valencia.
authors.forename: M
authors.initials: M
authors.lastname: Baquero
authors.forename: F J
authors.initials: FJ
authors.lastname: Domínguez-Sanz
authors.forename: J A
authors.initials: JA
authors.lastname: Burguera
authors.forename: G A
authors.initials: GA
authors.lastname: Cruz Campos
authors.forename: R
authors.initials: R
authors.lastname: Muñoz
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects; D002121:Calcium Channel Blockers / Q000009:adverse effects; D002936:Cinnarizine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D005444:Flunarizine / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000175:diagnosis / Q000209:etiology*; D010302:Parkinson Disease, Secondary / Q000175:diagnosis / Q000209:etiology*
chemical_list: D014150:Antipsychotic Agents; D002121:Calcium Channel Blockers; D006634:Histamine H1 Antagonists; D002936:Cinnarizine; D005444:Flunarizine
vernacular_title: Parkinsonismos de novo en ámbito extrahospitalario.